Skip to content
Sunday, 15 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Coronavirus

Vaccine passports: path back to normality or problem in the making?

A nurse prepares a dose of the Oxford/AstraZeneca Covid-19 vaccine at the NHS vaccine mass vaccination centre that has been set up in the grounds of Epsom Race Course, in Surrey, Britain 11 January 2021 (reissued 26 January 2021). AstraZeneca has denied reports of a reduced efficiacy of its COVID-19 vaccine. EPA-EFE/DOMINIC LIPINSKI / POOL

Governments and developers around the world are exploring the potential use of “vaccine passports” as a way of reopening the economy by identifying those protected against the coronavirus.

Those developing the technologies however, say such tools come with consequences such as potentially excluding whole groups from social participation, and are urging lawmakers to think seriously about how they are used.

The travel and entertainment industries, which have struggled to operate at a profit while imposing social distancing regulations, are particularly interested in a way of swiftly checking who has protection.

Among those developing passports are biometrics company iProov and cyber security firm Mvine which have built a vaccine pass now being tested within Britain’s National Health Service after receiving UK government funding.

iProov founder and chief executive Andrew Bud believes such vaccine passports only really need to hold two pieces of information.

“One is, has this person been vaccinated? And the other is, what does this person look like?”

You need only match a face to a vaccination status, you don’t need to know a person’s identity, he added.

via Reuters

Filed under CoronavirusTravel

More from Coronavirus

More →